Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 04-2005 | 01-2005 | 10-2004 | 07-2004 | 04-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,995 | 6,492 | 7,021 | -6,232 | -2,239 |
| Depreciation Amortization | 1,667 | 1,043 | 590 | 2,362 | 1,693 |
| Income taxes - deferred | 1,192 | 425 | 643 | -1,651 | -2,010 |
| Accounts receivable | -3,414 | -2,509 | -725 | -12,880 | -8,274 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 771 | N/A |
| Other Working Capital | -2,755 | -244 | 5,808 | -12,099 | -8,514 |
| Other Operating Activity | 7,452 | 5,143 | 2,141 | 24,147 | 16,736 |
| Operating Cash Flow | $9,137 | $10,350 | $15,478 | $-5,582 | $-2,608 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,589 | 4,725 | -1,098 | -2,349 | -287 |
| PPE Investments | -955 | -715 | -300 | -1,304 | -938 |
| Purchase Sale Intangibles | -20 | -21 | -21 | -444 | -414 |
| Other Investing Activity | -25 | -26 | -25 | -444 | -410 |
| Investing Cash Flow | $9,609 | $3,984 | $-1,423 | $-4,097 | $-1,635 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 348 | 290 | 65 | 896 | 841 |
| Other Financing Activity | 0 | 0 | 0 | 14 | 13 |
| Financing Cash Flow | $348 | $290 | $65 | $910 | $854 |
| Beginning Cash Position | 54,499 | 54,499 | 54,499 | 63,268 | 63,268 |
| End Cash Position | 73,593 | 69,123 | 68,619 | 54,499 | 59,879 |
| Net Cash Flow | $19,094 | $14,624 | $14,120 | $-8,769 | $-3,389 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,137 | 10,350 | 15,478 | -5,582 | -2,608 |
| Capital Expenditure | -955 | -715 | -300 | -1,304 | -938 |
| Free Cash Flow | 8,182 | 9,635 | 15,178 | -6,886 | -3,546 |